Drugs / Ca(OH)2
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03849222 | Aug 2013 → Apr 2016 | dental pulp necrosis | Al-Azhar University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07683520 | Oct 2025 → Jun 2026 | chronic apical periodontitis | Ain Shams University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06447519 | Sep 2024 → Sep 2026 overdue | — | Aristotle University Of Thessaloniki | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ca(OH)2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06447519 ↗ |
| Route | Other | “Ca(OH2 will be used as intracanal medicament for the disinfection of the root canal between appointmnents” NCT06447519 ↗ |